Liu, C

CURRICULUM VITAE

Date prepared: August, 2009

Chen Liu, M.D., Ph.D.

OFFICE ADDRESS:

University of Florida College of MedicineDepartment of Pathology, Immunology & Laboratory Medicine 1600 SW Archer Rd, M646, Gainesville, FL 32610Tel: 352-273-5413 Fax: 352-392-6249Email: liu@pathology.ufl.edu

CURRENT POSITIONEndowed Chair in Gastrointestinal and Liver ResearchDirector, Gastrointestinal and Liver Pathology SectionDirector, Gastrointestinal and Liver Pathology Fellowship ProgramCourse Director, GI Section of the Systemic Pathology for Medical Students Associate Professor of Pathology (tenured)Member of the Department Executive CommitteeUniversity of Florida College of Medicine, July 2000---

CLINICAL SPECIALTY

Surgical pathology specialized in gastrointestinal and liver pathology, AP/CP Board-Certified.

CURRENT RESEARCH PROGRAMS

Innate and adaptive immune response, and immunopathology of hepatitis C Viral infectionLiver cancer biomarker discovery and therapyAlpha-1 antitrypsin deficiency and liver diseaseGraft vs. Host Disease (GVHD)

EDUCATION

Surgical Pathology Fellow, UT MD Anderson Cancer Center, Houston, TXResident, AP/CP, Medical College of Pennsylvania, Philadelphia, PAPostdoctoral Fellow, Vogt Lab, Scripps Clinic and Research Foundation, La

Jolla, CAPh.D., Mason Lab, University of Pennsylvania School of Medicine,

Philadelphia, PAGraduate Training, Pekin Union Medical College, Beijing, ChinaM.D., Tong Liao Medical College, Tong Liao, China

1

Liu, C

CLINICAL EXPERIENCES

Surgical Pathologist , Shands Hospital at U. Florida2000--PresentSurgical Pathology Fellowship, UT M.D. Anderson Cancer Center 1999--2000Residency MCP-Hahnemann University Hospitals, Philadelphia, 1996--1999GI Liver Pathology Chester County Hospital, PA April 1-April 30, 1999GI Liver Pathology Yale University Department of Pathology Nov. 1-

Nov 30, 1998Dermatopathology University of Pennsylvania Dept. of Dermatology,

May 1-May 30, 1999

Hematology & Oncology Hahnemann University Hospital Department of Hematology

Sept.1, 1998-Oct. 31, 1998

RESEARCH EXPERIENCES

Residency Medical College of Pennsylvania Projects:Angiogenic activity in prostate cancer, liver cancer and soft tissue

tumorsHistopathology of HCV infection and apoptosisBeta catenin mutation in HCC using laser capture microdissection

Postdoctoral Fellow The Scripps Research Institute, Peter Vogt”s lab, La Jolla, California,

Projects: Gene transcription regulation and novel small molecule

inhibitorsCloning and characterization of protooncogene qin/BF1Development of Lox P and Cre knockout system

Graduate StudentUniversity of Pennsylvania School of Medicine, Graduate Program in Pathology, Bill Mason’s Lab. Projects:Liver specific transcription regulation of hepatitis B virusTissue tropism of hepatitis B viral infectionHepatocyte turnover and viral clearance

TEACHING EXPERIENCES

Fellowship Director, GI/Liver Pathology 2004-presentPathology Resident Teaching 2000-presentRotation Director, Molecular Pathology 2001-2007

2

Liu, C

Course Director, Systemic pathology GI-Liver section for 2nd year-medical students 2003-presentMentor, IDP graduate program at UF 2002-presentMentor, NIH-T32 training program in Gastroenterology. 2003-present Graduate student teaching 2000-present

AWARDSMid-career Mentor Award, National Institute of Health

2009Liver Research Scholar, American Liver Foundation2002Clinical Fellow Research Award, M.D. Anderson Cancer Center.

1999 Award from GI Pathology Society, 1998

House Staff Research Award, MCP Hahnemann University1997

Individual National Research Award, National Cancer Institute, NIH 1994

Scientific Merit Award, Ministry of Health, China 1988

Honored Outstanding Medical Graduate, TongLiao Medical College1985

RESEARCH GRANTS

Active:

National Institute of Health, NCRR, K26 (2009-2014), Principal Investigator. "Mouse Immunopathology".

National Institute of Health, NCI, R01 (2009-2014), Principal Investigator."Molecular targets for liver cancer diagnosis and therapy".

National Institute of Health, NHLBI, R21 (2005-2009), Principal Investigator, “Small molecules to treat alpha-a antitrypsin deficiency.”

National Institute of Health, NIAID, R01 (2005-2010), Co-Principal Investigator, “Innate and adaptive immune response in HCV patients.”

Alpha-one Foundation, Research grant, (2007-2009), Principal Investigator, “Therapeutic small molecules for alpha-1 antitrypsin deficiency.”

UF/Moffitt Cancer Center (2009-2010) Principal Investigator, "Immunotherapy for liver cancer"

3

Liu, C

UF/Moffitt Cancer Center (2009-2011) Principal Investigator, "Bone marrow transplantation for liver cancer therapy"

National Institute of Health, R01 (PI, Ferrara, U. Michigan,) co-investigator, multiple years

National Institute of Health, R01 (PI, Van den Brink, Memorial Sloane Kettering Cancer Center) co-investigator, multiple years

National Institute of Health, NIDDK R43 (2009 to 2011) (PI, Svetlov, Banyan Biotech Inc.) co-investigator

Pending:

National Institute of Health, R21 (2009-2011) Principal Investigator, "Red algae and innate immune regulators"

Projects completed:

Geyer Foundation for Cancer Research, (2008-2009), Principal Investigator, "Liver Cancer Biomarkers".

National Institute of Health, NIAID, R21 (2005-2008), Principal Investigator, “Murine model for hepatitis C virus.”

National Institute of Health, NIDDK, K08 (2002-2007), Principal Investigator, “ Role of liver cytokine expression in hepatitis C viral infection”

Florida Biomedical Research Program, (2007-2008), Co-PI, Biomarker discovery of liver cancer.

National Institute of Health, NIDDK, R03 (2005-2008), Principal Investigator, “Role of SOCS3 in Interferon Resistance.”

CellzDirect Corporation, (2005-2007), Principal Investigator, “Hepatic Registry Program.”

Howard Hughes Medical Institute (2000-2002) Startup Program.

Howard Hughes Medical Institute (2000-2003) Pilot project.

University of Florida Research Foundation (2002-2003) Opportunity research fund.

American Liver Foundation, (2003-2005), Principal Investigator, “Establishment and characterization of PiZZ liver cell lines.”

4

Liu, C

American Liver Foundation, (2002-2005), Principal Investigator, Liver scholar award

Children’s Miracle Network, (2005-2006), Principal Investigator, “Novel treatment for hepatoblastoma.”

Wyeth Research. (2003-2007), Investigator (PI, Abdelmalek), A Randomized, Open-Label, Comparative Evaluation of Conversion From Calcineurin Inhibitor Treatment To Sirolimus Treatment Versus

PROFESSIONAL CERTIFICATES

Board Certification (AP/CP) American Board of Pathology Medical Licensure State of FloridaPhysician and Surgeon Licensure, Commonwealth of PennsylvaniaValid ECMFG Certificate

PROFESSIONAL ACTIVITIES

Member of National Institutes of Health Study Section: GMA2 ZRG, 2003, 2005, 2006, 2007, 2008, 2009

Member of Education Committee, Hans Popper Hepatopathology Society. 2007 to present

Member of Basic Science Committee, American Association for the Study of Liver Disease, 2004-2008

Member of Tissue Bank Committee, Alpha-1 Foundation. 2005 to 2008.

Editorial Board, Laboratory Investigation, 2005- presentEditorial Board, International Journal of Clinical and Experimental Pathology. Editorial Board, World Journal of Gastroenterology.

Ad Hoc reviewer: J. Virology; Hepatology; Gastroenterology; Oncogene; American J. Pathology; Human Pathology; Lab Investigation; Cancer Research; J. Interferon Research; Human Immunology, FSEB letter.

Graduate student mentor, IDP graduate program, University of Florida.

COMMUNITY SERVICE

Science fair judge, Middle and high schools, Gainesville, FloridaChair, Board of Directors, Chinese School in Gainesville, Florida. Mentor, Healthcare policy internship program, Alachua County, Florida Mentor, Howard Hughes Medical Institute Undergraduate Research

PUBLICATIONS (Total 105)

Original Peer-Reviewed Articles:

5

Liu, C

1. Cardona D, Zhang XK, Liu C (2009) Absence of carbomyl phosphate synthetase I in small intestinal carcinoma. Am. J Clin Path. In Press.

2. Vila L, Liu HY, Al- Quran S, Coco D, Dong HJ, Liu C (2009) Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland. Modern Pathology. July 17. Epub adead of print.

3. Rotolo JA, Stancevic B, Lu, SX, Zhang J, Suh D, King CW, Murphy G, Liu C, van den Brink MRM (2009). Cytotoxic T cells induce ceramide-rich platform in target cell membrane to initiate graft versus host disease. Blood In press.

4. Stiffler JD, Nguyen M, Sohn JA, Liu C, Kaplan D, Seeger C. (2009) Focal distribution of hepatitis C virus RNA in infected livers. PLoS One. In Press

5. Abdelmalek M, Sanderson SO, Angulo P, Liu C, Peter J, Keach J, Cave M, Chen T, McClain CJ, Lindor KD. (2009). Btaine for nonalcoholic fatty liver disease: results of a randomized placebo controlled trial. Hepatology. In Press.

6. Penack O, Henke E, Suh D, Liu C, Lu T, May C, Scheinberg D, Gao DC, and Van den Brink M (2009) NOD2 regulates hematopoietic cell function during graft-versus-host disease. J. Exp. Med. In press

7. Kwan JC, Eksioglu E, Liu C, Paul V, Luesch (2009) Grassystatins A−C from Marine Cyanobacteria, Potent Cathepsin E Inhibitors that Reduce Antigen Presentation. J Med Chem. In Press

8. Glushakova LG, Lisankie MJ, Eruslanov EB, Ojano-Dirain CP, Zolotukhin I, Liu C, Stacpoole, P. (2009) AAV3-mediated Transfer and Expression of the Pyruvate Dehydrogenase E1 alpha Subunit Gene Causes Metabolic Remodeling and Apoptosis of Human Liver Cancer Cells. Molecular Genetics and Metabolism. In press.

9. Jin B, Yao B, Li JL, Fields R, Delmas AL, Liu C and Robertson (2009). DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modification in colon cancer. Cancer Research. In Press.

10. Cabrera R, Cao ME, Atkinson M, Wasserfall CH, Liu C, Nelson DR, (2009) Hepatocellular Carcinoma Immunopathogenesis: Clinical vvidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25). Dig. Dis. Sci. In press

11. Cao M, Cabrera R, Xu YL, Liu C, Nelson DR. (2009) Gamma irradiation alters the phenotype and function of CD4+CD25+ regulatory T cells. Cell Bio Int. 33:565-71

12. Olaf Penack, Erik Henke, David Suh, Chris King, Odette Smith, Il-Kang Na, Amanda Holland, Arnab Ghosh, Sydney Lu, Robert Jenq, Chen Liu, George Murphy, Theresa Lu, Chad May, David Scheinberg, Ding Cheng Gao, Vivek Mittal, Glenn Heller, Robert Benezra, and Marcel Van den Brink (2009) Inhibition of Neovascularization Simultaneously Ameliorates Graft-versus-host Disease and Decreases Tumor Growth. J. NCI. In Press

13. Kappel LW, Goldberg GL, King CG, Suh D, Smith OM, Ligh C, Holland A, Grubin J, Liu C, Iwakura Y, Mark N, Heller G, and van den Brink MRM (2009) IL-17 contributes to CD4-mediated graft-versus-host disease. Blood. 113:945-952.

14. Hildebrandt GC, Olkiewicz KM, Corrion L, Clouthier SG, Pierce EM, Liu C, Cooke KR (2008) A role for TNF receptor type II in leukocyte infiltration into

6

Liu, C

the lung during experimental idiopathic pneumonia syndrome. Biol Blood Marrow Transplant 14: 385-396

15. Butler SL, Dong HJ, Cardona D, Jia MH, Zheng R, Zhu HZ, Crawford JM and Liu C. (2008) The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. Lab Invest 88:78-88.

16. Liang Y, Liu C, Djeu JY, Zhong B, Peters T, Scharffetter-Kochanek K, Anasetti C, Yu XZ.(2008) β2 Integrins Separates Graft-versus-host disease and Graft-versus-leukemia effect. Blood 111(2):954-62

17. Reddy P, Sun Y, Toubai T, Duran-Struuck R, Clouthier SG, Weisiger E, Maeda Y, Tawara I, Krijanovski O, Gatza E, Liu C , Malter C, Mascagni P, Dinarello CA, Ferrara JL (2008) Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.J Clin Invest. 118(7):2562.

18. Gatza E, Rogers CE, Clouthier SG, Lowler KP, Tawara I, Liu C, Reddy P, Ferrara JL (2008) Blood. 112(4):1515-21

19. Tawara I, Maeda Y, Sun Y, Lowler KP, Liu C , Toubai T, McKenzie AN, Reddy P. (2008) Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease. Exp Hematol. 36(8):988-96

20. Liu C, Witek R, Bess, J, Zhu, HZ, Lin, P (2008) Repopulation of human hepatocytes in immunodeficient mice. FASEB J. 2008 22:465.4

21. Wu H.; Zhu, H; Zhuang, J.; Yang, S.; Liu,C.; Cao, Y.C. (2008) “Water-Soluble Nanocrystals Through Dual-Interaction Ligands.” Angew. Chem., 47: 3730-3734.

22. Kim TD, Terwey TH, Zakrzewski JL, Suh D, Kochman AA, Chen ME, King CG, Borsotti C, Grubin J, Smith OM, Heller G, Liu C, Murphy GF, Alpdogan O, van den Brink MR. (2008) Organ-derived dendritic cells have differential effects on alloreactive T cells. Blood. 2008 Mar 1;111(5):2929-40

23. Liu W, Grobmyer SR, Liu C, Hochwald SN (2007) Primary presacral neuroendocrine tumor associated with imperforate anus. World J Surg Onc. 5:115

24. Zhu HZ, Dong, HJ, Eksioglu E, Cao MD, Hemming, A, Crawford JM, Nelson DR, Liu C. (2007) Hepatitis C virus triggers apoptosis of a novel hepatoma cell line through innate antiviral defense system. Gastroenterology. 133:1649-1659.

25. Liu C , Zhu HZ, Nelson DR. (2007) Albuferon exhibits anti-HCV activity in cell culture. Hepatology Research. 2007 Nov;37(11):941-7.

26. Ramirez-Montagut T, Chow A, Kochman AA, Smith OM, Suh D, Sindhi H, Lu S, Borsotti C, Grubin J, Patel N, Terwey TH, Kim TD, Heller G, Murphy GF, Liu C, Alpdogan O, van den Brink MR. (2007) IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease. J Immunol. 2007 Aug 1;179(3):1669-80

27. Choi SW, Hildebrandt GC, Olkiewicz KM, Hanauer DA, Chaudhary MN, Silva IA, Rogers CE, Deurloo D, Fisher JM, Liu C, Adams D, Chensue SW, Cooke KR (2007) CCR1:CCL5 (RANTES) receptor ligand interactions modulates allogeneic T cell responses and reduces graft-versus-host disease following stem cell transplantation. Blood. 110(9):3447-55

7

Liu, C

28. Kim T, Grobmyer SR, Liu C, Hochwald SN. (2007) Primary presacral neuroendocrine tumor associated with imperforate anus. World J. Surg. Oncol. 5: 115

29. Duran-Struuck R, Tawara I, Lowler K, Clouthier SG, Weisiger E, Rogers C, Luker G, Kumanogoh A, Liu C, Ferrara JL, Reddy P.(2007) A novel role for the semaphorin Sema4D in the induction of allo-responses. 13(11):1294-1303

30. Cao M, Cabrera R, Xu Y, Zhu, H, Liu C, Nelson DR. (2007) Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells. Lab Invest. 87(6):582-90

31. Cardona D, Grobmyer S, Crawford JM, Liu C. (2007) Hepatocellular carcinoma arising from ectopic liver tissue in the pancreas. Virchows Arch. 450(2):225-9

32. Borsotti, C, Franklin AR, Lu, SX, Kim TD, Smith OM, Suh D, King CG, Chow A, Liu C, Alpdogan O, and van den Brink MR (2007) Absence of donor T cell derived soluble TNF decreases graft-versus-host-disease without impairing graft-versus-tumor activity. Blood 2007 Jul 15;110(2):783-6.

33. Abdelmalek MF, Liu C, Valentine JF. (2007) Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease. 102:1333

34. Winfield RD, Hochwald SN, Vogel SB, Hemming AW, Liu C, Cance WG, Grobmyer SR. Am Surg. 2006 Aug;72(8):719-22; discussion 722-3.

35. Abdemalek M, Liu C, Nelson D, Shuster J, Asal NR. (2006) Familial aggregation of insulin resistance in first degree relatives of patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology, 2006 Sep;4(9):1162-9.

36. Firpi RJ, Zhu HZ, Liu C, Nelson DR. (2006) Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of sustained virological response after liver transplantation. Liver Transplantation, 2006 Jan;12 (1):51-7.

37. Samara K, Liu C, Soldevila-Pico C, Nelson DR, Abdelmalek MF. (2006) Betaine resolves severe alcohol-induced hepatitis and steatosis following liver transplantation. Dig Dis Sci. 51:1226

38. Wang B, He J, Liu C, Chang LJ. (2006) An effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigens. Vaccine 24: 3477-89

39. Fujita S, Kushihata F, Herrmann GE, Mergo PJ, Liu C, Nelson DR, Hemming, AW (2006) Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomas. J. Gastro. Hepatology. 21(8):1351-4

40. Reddy P, Maeda Y, Liu C, Krijanovski O, Korngold R, Ferrara JLM. (2005), A critical role for antigen presenting cells and alloantigen expression in graft-versus-leukemia response after allogeneic bone marrow transplantation. Nature Medicine. Nov;11(11):1244-9

41. Zhu HZ, Butera M, Nelson DR, Liu C. (2005) Novel Type I interferon IL-28A suppresses hepatitis C virus. Virology J. 2:80.

42. Hubbard VM, Eng JM, Ramirez-Montagut T, Tjoe KH, Kochman AA, Terwey TH, Willis LM, Schiro R. Heller G, Murphy GF, Liu C, Alpdogan O, Van den Brink MR. (2005) Absence of inducible costimulator on alloreactive T cell reduces graft-versus-host disease and induces Th2 deviation. Blood, 2005 Nov 1;106(9):3285-92

8

Liu, C

43. Terwey TH, Kim TD, Kochman AA, Hubbard VM, Lu S, Zakrzewski JL, Ramirez-Montagut T, Eng JM, Muriglan SJ, Heller G, Murphy GF, Liu C, Budak-Alpdogan T, Alpdogan O, van den Brink MRM. (2005) CC chemokine receptor 2 is required for CD8-induced graft-versus-host disease. Blood. 2005 Nov 1;106(9):3322-30

44. Marsh RW, Walker MH, Liu C. (2005) Breast implants as a possible etiology of epithelioid hemangioendothelioma and successful therapy with interferon-alpha2. Breast J. 4: 257-261

45. Zhu HZ, Nelson DR, Crawford JM, Liu C. (2005) Defective JAK-STAT pathway is associated with HCV interferon resistance. J. Interferon & Cytokine Res., 25:528-539

46. Rufforny I , Wilkinson EJ, Zhu H, Buteral M, Liu C , Massoll NA. (2005) Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma J Low Genit Tract Dis. 9(2):108-13

47. Maeda Y, Reddy P, Lowler KP, Liu C, Bishop DK, FerraraJL. (2005) Critical role of host {gamma}{delta} T cells i experimental acute graft-versus-host disease. Blood. 2005 Jul 15;106(2):749-55

48. Gerbitz A, Ewing P, Olkiewicz K, Willmarth NE, Williams D, Hildebrandt G, Wilke A, Liu C, Eissner G, AndreesenR, Holler E, Guo R, Ward PA, Cooke KR. (2005) A role for CD54 (intercellular adhesion molecule-1) in leukocyte recruitment to the lung during the development of experimental idiopathic pneumonia syndrome.Transplantation,79:536-542

49. Cresawn KO, Fraites, TJ, Wasserfall C, Atkinson M, Lewis M, Porvasnik S, Liu C, Mah C, Byrne BJ. (2005) Correction of glycogen storage disease type II from intrahepatic delivery of rAAV and rAAV8 vectors is dependent on an inhibitory antibody response. Gene Therapy, 2005 Jan;16(1):68-80

50. Hashimoto D, Asakura, S, Miyake S, Yamamura T, Kaer L, Liu C, Tanimoto M, Teshima T. (2005) Stimulation of host natural killer T cells by synthetic glycolipid regulates acute graft-versus host disease by inducing Th2 polarization of donor T cells. J. Immunology, 174:551-556

51. Maeda Y, Levy RB, Reddy P, Liu C, Clouthier SG, Teshima T, Ferrara JL. (2005) Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease. Blood. 105:2023-2027.

52. Hildebrandt GC, Olkiewicz KM, Choi S, Corrion LA, Clouthier SG, Liu C, Serody JS, Cooke KR. (2005) Donor T cell-production of RANTES significantly contributes to the development of Idiopathic Pneumonia Syndrome after allogeneic stem cell transplantation. Blood, 105:2249-2257.

53. Zhu H, Shang X, Terada N, Liu C (2004) STAT3 induces anti-hepatitis C viral activity. Biochem Biophys Res Commun. 343:518-528

54. Shang XZ, Zhu HZ, Tu ZK, Nelson DR, Liu C (2004) Stabilized beta catenin promotes hepatocyte proliferation and inhibits TNF-induced apoptosis. Lab Investigation. 84:332-341

55. Gerbitz A, Nickoloff BJ, Olkiewicz K, Willmarth NE, Hildebrandt G, Liu C, Kobzik L, Eissner G, Holler E, Ferrara JL, Cooke KR. (2004) A role for tumor necrosis factor-alpha-mediated endothelial apoptosis in the development of experimental idiopathic pneumonia syndrome. Transplantation, 78:494-502

9

Liu, C

56. Li, M; Liu, C. (2004) Cytokeratin 20 confirms Merkel cell metastasis to stomach. Appl Immunohistochem Mol Morphol. 12:346-349.

57. Reddy P; Maeda, Y; Hotary, K; Liu, C; Reznikove, LL; Dinarello, CA, Ferrara, JM (2004) Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus leukemia effect. Proc, Natl. Acad. Sci. U.S.A, 101:3921-3926.

58. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, Nelson DR. (2004) An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology, 40: 1062-71.

59. Camp ER, Hochwald SN, Liu C. (2004) FAP with concurrent duodenal adenomatous polyposis and carcinoid tumor. J Surg Oncol. 87(4):187-90.

60. Min CK, Maeda Y, Lowler K, Liu C, Clouthier S, Lofthus D, Weisiger E, Ferrara JL, Reddy P. (2004) Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T cell subsets after experimental allogeneic bone marrow transplantation. Blood, 104:3393-3399.

61. Duffner, UA; Maeda, Y; Cooke, KR; Reddy, P; Ordemann, R; Liu, C; Ferrara, JL. (2004) Host dendritic cells alone are sufficient to initiate acute graft-versus-host-disease. J. Immunology. 172:7393-7398

62. Hildebrandt GC, Corrion, LA, Olkiewicz, KM, Lowler, K, Moore, BB, Kuziel, WA, Liu, C and Cooke, KR. (2004) Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome J. Immunology, 173:2050-9

63. Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR (2004) Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Liver Transpl. 10(2):199-207

64. Persad, R; Liu, C; Wu, TT; Houlihan, PS; Hamilton, SR; Diehl, AM, Rashid, A (2004) Overexpression of caspase 3 in hepatocellular carcinoma. Modern Pathology, 17(8) 1026.

65. Hildebrandt, GC; Olkiewicz, KM; Chang, Y; Liu, C; Cooke, KR (2004) Donor-dreived TNF regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogenic bone marraow transplantation. Blood, 104:586-93

66. Friedman JS, Alpdogan O, van den Brink MR, Liu C, Hurwitz D, Boyd A, Kupper TS, Burakoff SJ. (2004) Increasing T-cell age reduces effector activity but preserves proliferative capacity in a murine allogeneic major histocompatibility complex-mismatched bone marrow transplant model. Biol Blood Marrow Transplant.10:448-60.

67. Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Cabrera R, Shuster JJ, Theriaque D, Reed AI, Hemming AW, Liu C, Crawford JM, and Nelson DR.(2004) One-year Protocol Liver Biopsy Can Stratify Fibrosis Progression In Liver Transplant Recipients With Recurrent Hepatitis C Infection. Liver Transpl . 40:1062-71

68. Liu, C; Zhu, HZ; Xu, YL; Nelson, DR. (2003) CD8+ T cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity. Hepatology, 37:1335-1342

69. Hassanein A, Glanz S, Kessler H, Eskin T, Liu C (2003) Beta catenin is aberrantly expressed in tumors expression shadow cells: pilomatricoma,

10

Liu, C

craniopharyngioma, and calcifying odontogenic tumor. Am J Clinical Pathology. 120(5):732-6.

70. Zhu, H.Z; Zhao, HS; Collins, CD; Eckenrode, SE; Run, Q; McIndoe, RA; Crawford, JM; Nelson, DR; She, JX; Liu, C. Gene expression associated with IFN alpha antiviral activity in an HCV replicon cell line. (2003) Hepatology, 37:1180-1188. EDITORIAL: on page 975

71. Zhu, HZ; Liu, C. (2003) Interleukin 1 inhibits hepatitis C viral RNA replication by activation of extracellular regulated kinase pathway. J. Virology. 77:5493-5498

72. Petrovic, A; Alpdogan, O; Willis, LM; Eng, JM; Greenberg, AS; Kappel, BJ; Liu, C; Murphy, G; Heller, G and van den Brink, MR (2004) LPAM (/ integrin) is an important homing integrin on alloreactive T cells in the development of intestinal Graft-Versus-Host Disease. Blood.103: 1542-1547.

73. Ichiba T, Teshima T, Kuick R, Misek DE, Liu C, Takada Y, Maeda Y, Reddy P, Williams DL, Hanash S, Ferrara JL. (2003) Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotid microarrays. Blood 102(2):763-71

74. Teshima T, Reddy P, Liu C, Williams D, Cooke KR, Ferrara JL. (2003) Impaired thymic negative selection causes autoimmune graft-versus-host disease. Blood 102(2):429-35

75. Reddy P, Teshima T, Hildebrandt G, Williams DL, Liu C, Cooke KR, Ferrara JL. (2003) Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects. Blood 101(7):2877-85.

76. Clouthier S, Cooke KR, Teshima T, Lowler KP, Liu C, Connolly K, Ferrara JL (2003) Repifermin (Keratinocyte Growth Factor-2), delays onset of graft-versus-host disease while preserving a graft-versus-leukemia effect. Biology of Bone marrow, Blood and Transplantation. (9):592-603

77. Nelson DR, Tu Z, Soldevila-Pico C, Abdelmalek M, Zhu H, Xu YL, Liu, C, Davis GL (2003) Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology, 38(4):859-68

78. Duffner, U., Lu, B., Teshima, T., Williams, D.L., Hildebrandt, G., Reddy, P., Ordemann, R., Lowler, K., Liu, C., Cooke, K.R., and Ferrara J.L.M. (2003) Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol. (10):897-902 ,

79. Hildebrandt, G.C., Duffner, U.A., Olkiewicz, K.M., Willmarth, N.E., Corrion, L.A., Clouthier, S., Williams, D.L., Reddy, P.R., Moore, B.B., Liu, C., and K.R. Cooke. (2003). A Critical Role for CCR2 in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood, 2004 103:2417-2426.

80. Takanori Teshima1, Rainer Ordemann1, Pavan Reddy, Svetlana Gagin, Chen Liu, Kenneth R. Cooke & James L. M. Ferrara (2002) Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nature Medicine 8:575-581. (Cover article)

81. Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Reed A, Hemming A, Howard R, Van Der Werf W, Lauwers G, Liu C, Crawford JM, Davis GL, Nelson DR. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. Liver Transpl 2002 Nov;8(11):1000-1006

11

Liu, C

82. Ordemann R, Hutchinson R, Friedman J, Burakoff SJ, Reddy P, Duffner U, Braun TM, Liu C, Teshima T, Ferrara JL. (2002) Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease J. Clin Invest. 109:1249-56

83. Teshima, T; Reddy, P; Lowler, K; Kukuruga, M; Liu, C; Cooke, K; Ferrara, J (2002) Flt3 ligand modulates immune responses through expansion of CD8+ dentritic cells. Blood. 99:1825-1832.

84. Teshima, T; Liu, C; Lowler, KP; Dranoff, G; Ferrara J. (2002) Donor leukocyte infusion from immunized donors increases tumor vaccine efficiency after allogenic bone marrow transplantation. Cancer Research. 62:796-800.

85. Reddy, P; Teshima, T; Lowler, K; Kukuruga, M; Liu, C; Cooke, K; Ferrara, J (2001) Interleukin-18 regulates acute graft versus host disease by enhancing Fas mediated donor T cell apoptosis. J. Experimental Medicine. 194:1433-1440.

86. Guo, JT; Zhou, H; Liu, C; Aldrich, C; Saputelli, J; Whitaker, T; Barrasa, I; Mason, WS; Seeger, C. (2000) Viral clearance and hepatocyte turnover during hepatitis B infection in woodchucks. J. Virology 74:1495-1505

87. Ayala, G; Liu, C; Nicosia, R (2000) Microvasculature and VEGF expression in cartilaginous tumors. Human Pathology, 31:341-346

88. Guo, JT; Liu,C; Mason, WS; Pugh, JC (1998) Cloning and expression of a cDNA encoding the large subunit of duck replication factor C Biochimica et Biophysica Acta 1395:293-300

89. Liu, C; Smith, BC; Nicolaou, BM, Vogt, P (1996) Sequence selective carbohydrate DNA interaction: Dimeric and monomeric forms of the calicheamicin aryltetrasacchride interfere with transcription factor function. Proc, Natl. Acad. Sci. U.S.A 93:940-944

90. Liu, C; Mason, WS; Burch, JBE (1994) Identification of factor binding sites in duck hepatitis B virus and in vivo effects of enhancer mutations J Virology. 68:2286-2296

91. Mason, WS;Cullen, J; Saputelli, J; Wu, TT; Liu, C; London, WT; Lusterbader, E; Shaffer, P: O’connell, Aldrich, CE; Jilbert, AR (1994) Characterization of the antiviral effects of 2’carbodeoxyguanosine in duck chronically infected with duck hepatitis B virus Hepatology 19:398-411

92. Liu, C; Condreay, LD; Burch,JB; Mason, WS (1991) Characterization of the core promoter and enhancer of duck hepatits B virus Virology 184:242-252

93. Wu, TT; Condreay, LD; Liu, C; Mason, WS and Jibert, JR (1991) Hepadnavirus DNA synthesis. In: 1990 international symposium on viral hepatitis and liver disease ed. Hollinger, B; Margolis H; William and Wilkins. 114-121

94. Mason, WS; Summers, J; Liu, C; Condreay, LD;Wu, TT (1991) Chronic hepadnavirus infection. In: international symposium on hepatitis delta virus, ed. Gerin, J; Purcell; Rizetto, M Wiley-Liss, Inc. 235-242

95. Liu, C; Chen, HS (1988) Application of duck hepatocyte culture system in antiviral research Proc. Chinese Acad. Med. Sci. 4:455-457

Reviews and Chapters

96. Liu C ; Crawford JM. (2004) Chapter 17, Pathology of gastrointestinal tract. In “ Robbins Pathologic Basis of Disease”. 7 th edn. pp. 410-474

12

Liu, C

97. Liu C; Crawford JM. (2003) Liver anatomy. In: Madara ed. “Encyclopedia of Gastroenterology.” pp 510-515

98. Liu C ; Crawford JM. (2003) Liver biopsy. In: Madara ed. “Encyclopedia of Gastroenterology.” pp. 516-522.

99. Liu C ; Crawford JM. (2004) Graft-versus-Host Disease of the Liver. In: Ferrara ed. “Graft-vs-Host Disease.” 3 rd edn. Marcel Dekker, New Yrok. pp: 257-278

100. Liu C ; Crawford JM (2005) Chapter 17 and 18, in “Robbins and Cotran Pathologic Basis of Disease.” Pocket book. pp. 516-522

101. Liu C (2006) Hepatitis C Virology and Experimental Models. “Clinics in Liver Disease”. 10:773-791.

102. Liu C (2008) Primary Hepatocyte Culture in HCV Research. "Hepatitis C Protocols". In Press

103. Liu C , Crawford JM (2009) Chapter 18, Liver Pathology, in Robbins and Cotran Pathologic Basis of Disease, 8 th ed. In press.

104. Liu C Crawford JM. (2009) Pathological staging of biliary tract cancers. In Biliary Tract and Gallbladder Cancers. Pp. 77-84 Ed. Thomas and Fuller, Demos Medical, New York.

105. Kim Y, Liu C, Tan WH, (2009) Aptamers generated by cell-based SELEX for biomarker discovery. Future Medicine Biomarkers in Medicine. In press.

13